DK1039900T3 - Farmaceutisk præparat indeholdende sibutramin og orlistat - Google Patents

Farmaceutisk præparat indeholdende sibutramin og orlistat

Info

Publication number: DK1039900T3
Authority: DK; Denmark
Prior art keywords: compound; formula; orlistat; pharmaceutical preparation; preparation containing
Prior art date: 1997-12-24

Application number

DK98966345T

Other languages

Danish (da)

English (en)

Inventor

David John Heal

Helen Christine Jackson

Original Assignee

Abbott Gmbh & Co Kg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-24

Filing date

1998-12-16

Publication date

2004-10-04

1998-12-16 Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg

2004-10-04 Application granted granted Critical

2004-10-04 Publication of DK1039900T3 publication Critical patent/DK1039900T3/da

Links

AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 title 1
229960001243 orlistat Drugs 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1
UNAANXDKBXWMLN-UHFFFAOYSA-N sibutramine Chemical compound C=1C=C(Cl)C=CC=1C1(C(N(C)C)CC(C)C)CCC1 UNAANXDKBXWMLN-UHFFFAOYSA-N 0.000 title 1
229960004425 sibutramine Drugs 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 3
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
208000008589 Obesity Diseases 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
235000020824 obesity Nutrition 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Hematology (AREA)
Obesity (AREA)
Diabetes (AREA)
Cardiology (AREA)
Child & Adolescent Psychology (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

DK98966345T 1997-12-24 1998-12-16 Farmaceutisk præparat indeholdende sibutramin og orlistat DK1039900T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9727131.6A GB9727131D0 (en)	1997-12-24	1997-12-24	Therapeutic agents

Publications (1)

Publication Number	Publication Date
DK1039900T3 true DK1039900T3 (da)	2004-10-04

Family

ID=10824083

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK98966345T DK1039900T3 (da)	1997-12-24	1998-12-16	Farmaceutisk præparat indeholdende sibutramin og orlistat

Country Status (25)

Country	Link
US (1)	US6403641B2 (uk)
EP (1)	EP1039900B1 (uk)
JP (1)	JP2001527036A (uk)
KR (1)	KR20010033531A (uk)
CN (1)	CN1134257C (uk)
AT (1)	ATE268174T1 (uk)
AU (1)	AU758181B2 (uk)
BG (1)	BG104568A (uk)
BR (1)	BR9814498A (uk)
CA (1)	CA2315259A1 (uk)
CZ (1)	CZ20002392A3 (uk)
DE (1)	DE69824313T2 (uk)
DK (1)	DK1039900T3 (uk)
ES (1)	ES2222001T3 (uk)
GB (1)	GB9727131D0 (uk)
HU (1)	HUP0300615A3 (uk)
IL (1)	IL136733A (uk)
NO (1)	NO20003313L (uk)
NZ (1)	NZ505686A (uk)
PL (1)	PL342099A1 (uk)
PT (1)	PT1039900E (uk)
SK (1)	SK9492000A3 (uk)
TR (1)	TR200001869T2 (uk)
UA (1)	UA70310C2 (uk)
WO (1)	WO1999033450A2 (uk)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6339106B1 (en)	1999-08-11	2002-01-15	Sepracor, Inc.	Methods and compositions for the treatment and prevention of sexual dysfunction
US6476078B2 (en)	1999-08-11	2002-11-05	Sepracor, Inc.	Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6974838B2 (en)	1998-08-24	2005-12-13	Sepracor Inc.	Methods of treating or preventing pain using sibutramine metabolites
US6331571B1 (en)	1998-08-24	2001-12-18	Sepracor, Inc.	Methods of treating and preventing attention deficit disorders
GB9914744D0 (en) *	1999-06-24	1999-08-25	Knoll Ag	Therapeutic agents
US6399826B1 (en)	1999-08-11	2002-06-04	Sepracor Inc.	Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
CN100423715C (zh)	2000-07-28	2008-10-08	霍夫曼-拉罗奇有限公司	新型药物组合物
WO2002083631A1 (en)	2001-04-13	2002-10-24	Sepracor Inc.	Methods of preparing didesmethylsibutramine and other sibutramine derivatives
US6730319B2 (en) *	2001-06-06	2004-05-04	Hoffmann-La Roche Inc.	Pharmaceutical compositions having depressed melting points
CA2530634A1 (en) *	2003-06-12	2004-12-23	Menachem Rubinstein	Methods of treating obesity and related disorders using tellurium and selenium compounds
US20050131074A1 (en) *	2003-08-04	2005-06-16	Beckman Kristen M.	Methods for treating metabolic syndrome
AU2005239788A1 (en)	2004-05-10	2005-11-17	University Of Copenhagen	Flaxseeds for body weight management
EP2190303A1 (en)	2007-09-12	2010-06-02	Københavns Universitet	Compositions and methods for increasing the suppression of hunger and reducing the digestibility of non-fat energy satiety
US20090214682A1 (en) *	2008-02-22	2009-08-27	Heuer Marvin A	Composition and methods for weight loss in a subject
JP5738011B2 (ja) *	2011-03-04	2015-06-17	株式会社ブリヂストン	二次電池の非水電解液用添加剤、二次電池用非水電解液及び非水電解液二次電池
CN102872062A (zh) *	2011-07-13	2013-01-16	鲁南制药集团股份有限公司	一种治疗或预防肥胖症以及代谢综合症的药物组合物
JP2013147488A (ja) *	2011-12-21	2013-08-01	Taisho Pharmaceutical Co Ltd	固形製剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IE52768B1 (en)	1981-04-06	1988-02-17	Boots Co Ltd	1-arylcyclobutylalkylamine compounds useful as therapeutic agents
CA1247547A (en) *	1983-06-22	1988-12-28	Paul Hadvary	Leucine derivatives
CA1328881C (en)	1984-12-21	1994-04-26	Pierre Barbier	Process for the manufacture of oxetanones
GB8531071D0 (en)	1985-12-17	1986-01-29	Boots Co Plc	Therapeutic compound
GB8704777D0 (en)	1987-02-28	1987-04-01	Boots Co Plc	Medical treatment
JP2675573B2 (ja)	1988-03-31	1997-11-12	科研製薬株式会社	脳機能改善剤
IE61928B1 (en)	1988-11-29	1994-11-30	Boots Co Plc	Treatment of obesity
TW381025B (en)	1993-08-05	2000-02-01	Hoffmann La Roche	Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor
US5459164A (en)	1994-02-03	1995-10-17	Boots Pharmaceuticals, Inc.	Medical treatment

1997
- 1997-12-24 GB GBGB9727131.6A patent/GB9727131D0/en not_active Ceased
1998
- 1998-12-16 ES ES98966345T patent/ES2222001T3/es not_active Expired - Lifetime
- 1998-12-16 KR KR1020007007034A patent/KR20010033531A/ko not_active Ceased
- 1998-12-16 IL IL13673398A patent/IL136733A/en not_active IP Right Cessation
- 1998-12-16 PT PT98966345T patent/PT1039900E/pt unknown
- 1998-12-16 DE DE69824313T patent/DE69824313T2/de not_active Expired - Fee Related
- 1998-12-16 HU HU0300615A patent/HUP0300615A3/hu unknown
- 1998-12-16 CN CNB988137399A patent/CN1134257C/zh not_active Expired - Fee Related
- 1998-12-16 PL PL98342099A patent/PL342099A1/xx unknown
- 1998-12-16 WO PCT/EP1998/008249 patent/WO1999033450A2/en not_active Ceased
- 1998-12-16 JP JP2000526207A patent/JP2001527036A/ja active Pending
- 1998-12-16 AU AU22738/99A patent/AU758181B2/en not_active Ceased
- 1998-12-16 CZ CZ20002392A patent/CZ20002392A3/cs unknown
- 1998-12-16 BR BR9814498-7A patent/BR9814498A/pt not_active IP Right Cessation
- 1998-12-16 DK DK98966345T patent/DK1039900T3/da active
- 1998-12-16 UA UA2000074417A patent/UA70310C2/uk unknown
- 1998-12-16 CA CA002315259A patent/CA2315259A1/en not_active Abandoned
- 1998-12-16 US US09/212,249 patent/US6403641B2/en not_active Expired - Fee Related
- 1998-12-16 EP EP98966345A patent/EP1039900B1/en not_active Expired - Lifetime
- 1998-12-16 AT AT98966345T patent/ATE268174T1/de not_active IP Right Cessation
- 1998-12-16 TR TR2000/01869T patent/TR200001869T2/xx unknown
- 1998-12-16 NZ NZ505686A patent/NZ505686A/en unknown
- 1998-12-16 SK SK949-2000A patent/SK9492000A3/sk unknown
2000
- 2000-06-23 NO NO20003313A patent/NO20003313L/no not_active Application Discontinuation
- 2000-06-28 BG BG104568A patent/BG104568A/bg unknown

Also Published As

Publication number	Publication date
JP2001527036A (ja)	2001-12-25
NZ505686A (en)	2002-07-26
EP1039900A2 (en)	2000-10-04
DE69824313D1 (de)	2004-07-08
KR20010033531A (ko)	2001-04-25
TR200001869T2 (tr)	2000-10-23
CZ20002392A3 (cs)	2002-01-16
US20020010160A1 (en)	2002-01-24
US6403641B2 (en)	2002-06-11
HUP0300615A2 (hu)	2003-07-28
PL342099A1 (en)	2001-05-21
EP1039900B1 (en)	2004-06-02
CA2315259A1 (en)	1999-07-08
CN1284872A (zh)	2001-02-21
DE69824313T2 (de)	2005-08-25
CN1134257C (zh)	2004-01-14
AU758181B2 (en)	2003-03-20
ATE268174T1 (de)	2004-06-15
PT1039900E (pt)	2004-09-30
HK1034446A1 (en)	2001-10-26
GB9727131D0 (en)	1998-02-25
NO20003313D0 (no)	2000-06-23
AU2273899A (en)	1999-07-19
BR9814498A (pt)	2000-10-10
HUP0300615A3 (en)	2005-04-28
BG104568A (bg)	2001-02-28
WO1999033450A2 (en)	1999-07-08
IL136733A (en)	2004-08-31
SK9492000A3 (en)	2001-07-10
NO20003313L (no)	2000-08-11
WO1999033450A3 (en)	1999-09-02
IL136733A0 (en)	2001-06-14
ES2222001T3 (es)	2005-01-16
UA70310C2 (uk)	2004-10-15

Publication	Publication Date	Title
DK0869808T3 (da)	2006-11-13	Anvendelse af Glu-Trp-dipeptider til fremstilling af et lægemiddel til behandling af forskellige tilstande, der involverer neovaskularisation
CY1107391T1 (el)	2010-07-28	Αρυλσυμπυκνωμενες αζαπολυκυκλικες ενωσεις
DE69824313D1 (de)	2004-07-08	Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen
ES2295609T3 (es)	2008-04-16	Derivados de tiadiazolilpiperazina utiles para tratar o prevenir un dolor.
GEP20043269B (en)	2004-06-25	Purine Derivatives, Method for Their Production and Composition Containing the Same
BG106095A (bg)	2002-06-28	Нови лекарствени състави на базата на антихолинергично активни съединения и бета-миметици
DK1346041T3 (da)	2007-07-02	Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom
NO2005024I1 (no)	2005-11-14	Heksylaminolevulinat, eventuelt i form av et salt,fortinnsvis heksylaminolevulinathydroklorid
DK1014966T3 (da)	2006-12-04	Farmaceutisk præparat til behandling af neurologiske og neuropsykiatriske lidelser
LU91254I2 (fr)	2006-08-28	Daptomycine et ses dérivés pharmaceutiquement acceptables (cubicinr)
DK0998287T3 (da)	2003-09-01	Anvendelse af levobupivacain
DK0652000T3 (da)	2001-11-12	Anvendelse af 2-phenyl-3-aroylbenzothiophener til fremstilling af et lægemiddel til inhibering af angiogenese og angiogene sygdomme
NO994165L (no)	1999-10-25	Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
DK0736029T3 (da)	2006-05-15	Antikonvulsive pseudofructopyranosesulfamater
GB9108629D0 (en)	1991-06-12	Heterocyclic pharmaceutical compounds,preparation and use
MXPA01012936A (es)	2004-04-21	Composicion farmaceutica que contiene sibutramina y orlistat.
NO20031410D0 (no)	2003-03-27	Antitumorterapi innbefattende distamycinderivater
BG106209A (en)	2002-09-30	Therapeutic agents
SE0004827D0 (sv)	2000-12-22	Therapeutic compounds
RU97117735A (ru)	1999-07-10	Способ лечения дифтерии
FI930097A7 (fi)	1993-01-11	Annostusmuoto lääkeaineen antamiseksi vuorokausiterapian toteuttamista varten
WO2003004019A8 (en)	2003-08-14	Use of heterocyclic and benzoheterocyclic polyamides structurally related to the natural antibiotic distamycin a for the treatment of beta-thalassaemia
MD1469F1 (en)	2000-05-31	Method of treatment of the burn shock
RU99118112A (ru)	2001-06-20	Способ лечения больных с невротическими расстройствами препаратом "миелопид"
UA15281A (uk)	1997-06-30	Спосіб лікуваhhя хроhічhої ішемічhої хвороби серця